Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Taiwan Liposome Ltd.

    NASDAQ: TLC · Real-Time Price · USD
    7.00
    0.00 (0.00%)
    At close: Apr 24, 2025, 3:47 PM

    Taiwan Liposome Statistics

    Share Statistics

    Taiwan Liposome has - shares outstanding. The number of shares has increased by null% in one year.

    Shares Outstanding

    n/a
    		 n/a

    Shares Change (YoY)

    n/a
    		 n/a

    Shares Change (QoQ)

    n/a
    		 n/a

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -5 and the forward PE ratio is null. Taiwan Liposome's PEG ratio is -4.93.

    PE Ratio

    n/a
    		 -5

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 48.21

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 11.22

    P/FCF Ratio

    n/a
    		 -5.4

    PEG Ratio

    n/a
    		 -4.93
    Financial Ratio History

    Enterprise Valuation

    Taiwan Liposome has an Enterprise Value (EV) of 4.24B.

    EV / Sales

    n/a
    		 41.58

    EV / EBITDA

    n/a
    		 -4.66

    EV / EBIT

    n/a
    		 -4.84

    EV / FCF

    n/a
    		 -4.66

    Financial Position

    The company has a current ratio of 4.11, with a Debt / Equity ratio of 1.52.

    Current Ratio

    n/a
    		 4.11

    Quick Ratio

    n/a
    		 4.11

    Debt / Equity

    n/a
    		 1.52

    Debt / EBITDA

    n/a
    		 -0.73

    Debt / FCF

    n/a
    		 -0.73

    Interest Coverage

    n/a
    		 -60.12

    Financial Efficiency

    Return on Equity is -224.54% and Return on Invested Capital is -89.05%.

    Return on Equity

    n/a
    		 -224.54%

    Return on Assets

    n/a
    		 -56.21%

    Return on Invested Capital

    n/a
    		 -89.05%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 n/a

    Employee Count

    n/a
    		 undefined

    Asset Turnover

    n/a
    		 0.06

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 1.13M

    Effective Tax Rate

    n/a
    		 -0.12%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 0.8, so Taiwan Liposome's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.8

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 n/a

    200-Day Moving Average

    n/a
    		 n/a

    Relative Strength Index (RSI)

    n/a
    		 n/a

    Average Volume (20 Days)

    n/a
    		 17,612

    Income Statement

    In the last 12 months, Taiwan Liposome had revenue of 101.93M and earned -983.31M in profits. Earnings per share was -24.89.

    Revenue

    n/a
    		 101.93M

    Gross Profit

    n/a
    		 101.93M

    Operating Income

    n/a
    		 -983.11M

    Net Income

    n/a
    		 -983.31M

    EBITDA

    n/a
    		 -909.66M

    EBIT

    n/a
    		 -965.82M

    Earnings Per Share (EPS)

    n/a
    		 -24.89
    Full Income Statement

    Balance Sheet

    The company has 1.34B in cash and 667.38M in debt, giving a net cash position of 675.28M.

    Cash & Cash Equivalents

    n/a
    		 1.34B

    Total Debt

    n/a
    		 667.38M

    Net Cash

    n/a
    		 675.28M

    Retained Earnings

    n/a
    		 -2.7B

    Total Assets

    n/a
    		 n/a

    Working Capital

    n/a
    		 n/a
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -875.19M and capital expenditures -34.38M, giving a free cash flow of -909.57M.

    Operating Cash Flow

    n/a
    		 -875.19M

    Capital Expenditures

    n/a
    		 -34.38M

    Free Cash Flow

    n/a
    		 -909.57M

    FCF Per Share

    n/a
    		 -23.02
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -964.51% and -964.71%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -964.51%

    Pretax Margin

    n/a
    		 -963.6%

    Profit Margin

    n/a
    		 -964.71%

    EBITDA Margin

    n/a
    		 -892.45%

    EBIT Margin

    n/a
    		 -964.51%

    FCF Margin

    n/a
    		 -892.36%

    Dividends & Yields

    TLC does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -20.01%

    FCF Yield

    n/a
    		 -18.51%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for TLC.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 n/a

    Piotroski F-Score

    n/a
    		 n/a

    Add to Watchlist